Development of Simplified in Vitro P‑Glycoprotein
Substrate Assay and in Silico Prediction Models To Evaluate Transport
Potential of P‑Glycoprotein
Version 3 2019-06-03, 23:43Version 3 2019-06-03, 23:43
Version 2 2019-04-16, 14:43Version 2 2019-04-16, 14:43
Version 1 2019-04-16, 14:40Version 1 2019-04-16, 14:40
Posted on 2019-06-03 - 23:43
For
efficient drug discovery and screening, it is necessary to
simplify P-glycoprotein (P-gp) substrate assays and to provide in
silico models that predict the transport potential of P-gp. In this
study, we developed a simplified in vitro screening method to evaluate
P-gp substrates by unidirectional membrane transport in P-gp-overexpressing
cells. The unidirectional flux ratio positively correlated with parameters
of the conventional bidirectional P-gp substrate assay (R2 = 0.941) and in vivo Kp,brain ratio (mdr1a/1b KO/WT) in mice (R2 =
0.800). Our in vitro P-gp substrate assay had high reproducibility
and required approximately half the labor of the conventional method.
We also constructed regression models to predict the value of P-gp-mediated
flux and three-class classification models to predict P-gp substrate
potential (low-, medium-, and high-potential) using 2397 data entries
with the largest data set collected under the same experimental conditions.
Most compounds in the test set fell within two- and three-fold errors
in the random forest regression model (71.3 and 88.5%, respectively).
Furthermore, the random forest three-class classification model showed
a high balanced accuracy of 0.821 and precision of 0.761 for the low-potential
classes in the test set. We concluded that the simplified in vitro
P-gp substrate assay was suitable for compound screening in the early
stages of drug discovery and that the in silico regression model and
three-class classification model using only chemical structure information
could identify the transport potential of compounds including P-gp-mediated
flux ratios. Our proposed method is expected to be a practical tool
to optimize effective central nervous system (CNS) drugs, to avoid
CNS side effects, and to improve intestinal absorption.
CITE THIS COLLECTION
DataCite
DataCiteDataCite
3 Biotech3 Biotech
3D Printing in Medicine3D Printing in Medicine
3D Research3D Research
3D-Printed Materials and Systems3D-Printed Materials and Systems
4OR4OR
AAPG BulletinAAPG Bulletin
AAPS OpenAAPS Open
AAPS PharmSciTechAAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität HamburgAbhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)ABI Technik (German)
Academic MedicineAcademic Medicine
Academic PediatricsAcademic Pediatrics
Academic PsychiatryAcademic Psychiatry
Academic QuestionsAcademic Questions
Academy of Management DiscoveriesAcademy of Management Discoveries
Academy of Management JournalAcademy of Management Journal
Academy of Management Learning and EducationAcademy of Management Learning and Education
Academy of Management PerspectivesAcademy of Management Perspectives
Academy of Management ProceedingsAcademy of Management Proceedings
Academy of Management ReviewAcademy of Management Review
Ohashi, Rikiya; Watanabe, Reiko; Esaki, Tsuyoshi; Taniguchi, Tomomi; Torimoto-Katori, Nao; Watanabe, Tomoko; et al. (2019). Development of Simplified in Vitro P‑Glycoprotein
Substrate Assay and in Silico Prediction Models To Evaluate Transport
Potential of P‑Glycoprotein. ACS Publications. Collection. https://doi.org/10.1021/acs.molpharmaceut.8b01143